Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abstract, acid, AEs, BIBF, Charleston, consumption, correlated, daily, deoxyribonucleic, EHA, endothelial, febrile, glycolytic, goal, immature, insight, insufficient, Jakafi, Jakavi, Kevan, learn, Madrid, marrow, mCR, meaningful, metastatic, mg, morphologic, mortality, myeloma, myelosuppression, neutropenia, nintedanib, nonvested, ofCancer, oxidative, oxygen, paper, path, primed, pronounced, ratably, ruxolitinib, shifted, South, Spanish, thrombocytopenia, TKI, unexpected, vascular, VEGFr
Removed:
accounted, adjustment, Alvero, amending, anniversary, appointment, arithmetic, Australia, average, classification, consecutive, consulting, contemplated, counsel, creating, customary, depository, derivative, encouraging, exceeded, expired, extinguishment, FDASIA, feature, geographic, gynecological, highest, historically, holder, increasing, instrument, International, issuing, joined, lower, lowest, multicenter, NADH, occurrence, oxidase, preceding, President, principally, professional, proportionate, propose, recently, refer, refund, reinvest, remove, revalued, science, secondary, separate, settled, subscription, Supplemental, unutilized, Vice, voluntary, weighted, wholly, wind, yield
Filing tables
Filing exhibits
Related press release
MEIP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
MEI Pharma, Inc.
San Diego, CA
We hereby consent to the incorporation by reference in the Registration Statements on FormS-3 (File Nos. 333-195122, 333-191893, 333-186070, 333-184011, 333-174789, 333-146453 and 333-136440) and FormS-8 (File Nos. 333-201703, 333-179591, 333-174790, 333-169719, and 333-156985) of MEI Pharma, Inc. of our reports dated September 1, 2015, relating to the financial statements and the effectiveness of MEI Pharma, Inc.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
San Diego, California
September 1, 2015